CLINICAL EXOME

Clinical Exome is an advanced genomic sequencing test that analyzes thousands of clinically relevant genes associated with known human diseases. Using Next Generation Sequencing (NGS) technology, the test evaluates the protein-coding regions (exons) of genes that are known to be linked to inherited disorders, developmental abnormalities, neurological conditions, metabolic diseases, and numerous other genetic syndromes.

Clinical Exome testing is a powerful diagnostic tool for patients with unexplained medical conditions, suspected genetic disorders, developmental delays, intellectual disabilities, congenital anomalies, or rare diseases. By examining disease-associated genes simultaneously, the test can help identify the underlying genetic cause of complex clinical presentations.

Benefits of the Test

• Provides comprehensive analysis of clinically relevant genes.
• Helps identify the genetic cause of unexplained disorders.
• Supports diagnosis of rare and inherited diseases.
• Evaluates multiple disease-associated genes simultaneously.
• Supports personalized medical management.
• Assists genetic counseling and family planning.
• Reduces the need for multiple individual genetic tests.
• Uses advanced Next Generation Sequencing technology.

Why Doctors Recommend This Test

Doctors recommend Clinical Exome testing for patients with suspected genetic disorders, developmental delay, intellectual disability, epilepsy, neuromuscular disorders, congenital anomalies, metabolic diseases, unexplained medical conditions, or a strong family history of inherited disorders. The test is particularly valuable when routine investigations have failed to identify the underlying cause of a condition.

Comprehensive genomic analysis helps clinicians establish accurate diagnoses and guide individualized treatment and management strategies.

Preparation Before Test

• No fasting is generally required.
• A blood sample is usually collected for testing.
• Detailed clinical information should be provided.
• Family medical history may be requested.
• Genetic counseling may be recommended before testing.
• Follow all sample collection instructions provided by healthcare professionals.

Normal Reporting Time

Most Clinical Exome reports at Focus Diagnostics are available within 2–3 hours for specimen processing and sequencing workflow initiation. Final sequencing analysis, bioinformatics interpretation, variant classification, and reporting generally require several working weeks due to the complexity of genomic data analysis.

Who Should Take This Test?

This test may be recommended for:

• Patients with suspected genetic disorders.
• Children with developmental delay or intellectual disability.
• Individuals with unexplained neurological conditions.
• Patients with rare or undiagnosed diseases.
• People with congenital anomalies.
• Individuals with inherited metabolic disorders.
• Families seeking genetic diagnosis.
• Patients requiring comprehensive genomic evaluation.

Detailed Information

The human genome contains approximately 20,000 genes, many of which play essential roles in normal growth, development, metabolism, and overall health. Genetic changes within these genes can lead to a wide variety of inherited disorders, ranging from mild conditions to severe multisystem diseases. Identifying the specific genetic cause of a disorder is often critical for accurate diagnosis and patient management.

Clinical Exome testing focuses on sequencing the exons of clinically significant genes known to be associated with human disease. Although exons represent only a small portion of the genome, they contain the majority of disease-causing genetic variants identified in clinical practice. This makes Clinical Exome testing an efficient and highly informative diagnostic approach.

Using advanced Next Generation Sequencing (NGS) technology, thousands of disease-associated genes are analyzed simultaneously. Sophisticated bioinformatics tools are then used to identify genetic variants that may explain the patient's clinical presentation. Variants are interpreted according to internationally accepted guidelines and classified as pathogenic, likely pathogenic, uncertain significance, likely benign, or benign.

Clinical Exome testing is commonly used in the evaluation of developmental disorders, intellectual disability, epilepsy, neuromuscular diseases, inherited metabolic disorders, congenital anomalies, cardiomyopathies, immunodeficiency syndromes, endocrine disorders, and many rare genetic conditions. The test can provide answers for patients who have undergone extensive diagnostic evaluations without obtaining a definitive diagnosis.

A confirmed genetic diagnosis may influence treatment decisions, prognosis assessment, surveillance recommendations, reproductive planning, and family risk evaluation. In some cases, identifying a genetic cause may allow access to targeted therapies or participation in specialized clinical programs.

Because genomic testing may reveal complex findings, results are interpreted by experienced molecular geneticists and often accompanied by genetic counseling. Family member testing may sometimes be recommended to clarify variant significance and inheritance patterns.

At Focus Diagnostics, Clinical Exome testing is performed using advanced Next Generation Sequencing platforms, comprehensive bioinformatics analysis, and stringent quality assurance standards to provide accurate, reliable, and clinically meaningful genetic diagnostic information.